Embracing technology: professional end-users’ perspectives on digital neuropsychological assessment in cognitive rehabilitation

This study aimed to explore the perspectives of healthcare professionals, both with and without previous experience of digital neuropsychological assessment (d-NPA), on the use of supervised d-NPA for cognitive assessment. Specifically, the study sought to: (1) understand how these professionals define d-NPA, and (2) examine the perceived benefits and limitations of its use. An online survey was administered from May to June 2021, employing qualitative analysis to summarise meaningful relationships within the data. Respondents were divided into four groups: psychologists with d-NPA experience, psychologists without d-NPA experience, other professionals with d-NPA experience, and other professionals without d-NPA experience. Descriptive statistics and frequency analyses of qualitative codes were performed, followed by logistic regression to identify significant group differences. A total of 284 respondents completed the survey. Most respondents perceived d-NPA as a standardised digital cognitive assessment administered and scored via computer or tablet, suitable for both traditional face-to-face settings (with a clinician) and remote, unsupervised settings. Key benefits included efficiency, improved accuracy (with more sophisticated tests and outcome measures), and reduced workload. Concerns primarily focused on challenges with digital literacy, the suitability of digital assessments for specific patient populations, and the potential loss of qualitative observational data. Group comparisons revealed no significant differences between healthcare professionals with and without previous d-NPA experience, suggesting a shared perspective on the benefits and limitations of d-NPA. These findings emphasise the need to develop user-friendly digital systems through close collaboration with end-users, ensuring that digital assessments address validity concerns and tailor to patients' specific needs. Addressing these challenges can enhance the accessibility and efficacy of d-NPA for a broad clinical population.